Open Access 07.09.2021 | Correction
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL
Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 12/2021
Open Access 07.09.2021 | Correction
Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 12/2021